News

Amyotrophic Lateral Sclerosis (ALS) and Psoriasis Patients Receive Brazilian Government Permission to Be Treated with Medical Marijuana, Inc. Subsidiary, HempMeds® Brasil, Flagship Product RSHO™

July 19, 2017

general_hemp_blog_images_03-01-17_ver1

SAN DIEGO, July 19, 2017 /PRNewswire/ — Medical Marijuana, Inc. (MJNA) is the first publicly traded cannabis company in the United States. Its subsidiary HempMeds® Brasil today announced that the Company’s hemp cannabidiol (CBD) oil product Real Scientific Hemp Oil™ [RSHO™] has been prescribed by doctors in the country for the treatment

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil To Hold Country’s First-Ever Symposium On Medical Cannabis For Health Professionals

March 30, 2017

general_hemp_blog_images_03-01-17_ver1

Company to Educate Brazilian Medical Community on Therapeutic Uses of Cannabis, Importation Rules to Provide Patients Greater Access SAN DIEGO, March 30, 2017 — Medical Marijuana, Inc. ( MJNA ), the first publicly traded cannabis company in the United States, today

Medical Marijuana, Inc. Clarifies Operations Unaffected by White House Statements Hinting at Recreational Marijuana Crackdown

March 1, 2017

general_hemp_blog_images_03-01-17_ver1 (1)

SAN DIEGO, March 1, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, is reassuring customers, shareholders, and the public that the company’s operations in the federally legal hemp cannabidiol (CBD) market are unaffected by

Autism Approval: Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Receives Brazilian Government Permission for Import of Flagship Product RSHO™

March 1, 2017

general_hemp_blog_images_03-01-17_ver1

SAN DIEGO, Feb. 28, 2017 — Medical Marijuana, Inc. (OTC PINK:MJNA), the first publicly traded cannabis company in the United States, subsidiary HempMeds® Brasil today announced that the Brazilian government approved a prescription for the Company’s cannabidiol (CBD) oil product Real

Multiple Sclerosis Approval: Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Receives Brazilian Government Permission for Import of Flagship Product RSHO™

February 23, 2017

general-hemp-blog-images-17-01-05-ver1

SAN DIEGO, Feb. 21, 2017 — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, subsidiary, HempMeds® Brasil today announced that the Brazilian government has authorized a doctor’s prescription for the Company’s hemp cannabidiol (CBD) oil product

Medical Marijuana, Inc. Subsidiary, HempMeds Brasil Featured in ‘Veja’ Article Highlighting Brazilian Health Authority Approval of RSHO™ on Patients with Alzheimer’s Disease

February 15, 2017

general_hemp_blog_tech_medicine_02-02-17_ver1

Article details the groundbreaking decision and possible implications for Alzheimer’s patients SAN DIEGO, Feb. 15, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC PINK:MJNA), the first-ever publicly traded Cannabis Company in the United States, subsidiary HempMeds® Brasil was featured in a Veja.com

Alzheimer’s Patient Receives Brazilian Government Permission to be Treated with Medical Marijuana, Inc. Subsidiary, HempMeds® Brasil, Flagship Product RSHO™

February 7, 2017

general-hemp-blog-images-17-01-05-ver1

National Health Surveillance Agency ANVISA Authorizes Doctor’s Prescription for RSHO™ to Treat Patient Suffering from Effects of Alzheimer’s Disease SAN DIEGO, Feb. 7, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC PINK:MJNA), the first publicly traded cannabis company in the United States,

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches New Website

February 2, 2017

general_hemp_blog_tech_medicine_02-02-17_ver1

SAN DIEGO, Feb. 2, 2017 — Medical Marijuana, Inc. (OTC PINK:MJNA), the first publicly traded cannabis company in the United States, announced today that its subsidiary HempMeds Brasil™ has launched a new website featuring brand information, a navigable web interface layout,

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Begins Importation of RSHO™ Green Label Into Brazil

February 1, 2017

general-hemp-blog-images-17-01-05-ver1

AN DIEGO, Feb. 1, 2017  — Medical Marijuana, Inc. (otc pink:MJNA), the first publicly traded cannabis company in the United States, announced today that its subsidiary HempMeds® Brasil has begun the process of importing its Real Scientific Hemp Oil™ (RSHO) Green

Medical Marijuana, Inc. Subsidiary, HempMeds® Brasil Announces Groundbreaking Distribution Partnership with Paragon HealthCare BR

January 5, 2017

general-hemp-blog-images-17-01-05-ver1

Partnership to Provide Expanded Accessibility to RSHO(TM), the First-Ever Product Approved for Import by Brazilian Government SAN DIEGO, CA — (Marketwired) — 01/05/17 — Medical Marijuana, Inc.(OTC PINK:MJNA), the first-ever publicly traded cannabis company in the United States, has announced